Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13D for IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX).
- Disclosed ownership: 10%.
- Date of event: 12 Feb 2026.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX) on 12 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 7.4% | 10,113,585 | 0 | 10,113,585 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0000918923 |
| BVF I GP LLC | 7.4% | 10,113,585 | 0 | 10,113,585 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803805 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.2% | 3,027,105 | 0 | 3,027,105 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001102444 |
| BVF II GP LLC | 2.2% | 3,027,105 | 0 | 3,027,105 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803806 |
| Biotechnology Value Trading Fund OS LP | 0.3% | 427,629 | 0 | 427,629 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660683 |
| BVF Partners OS Ltd. | 0.3% | 427,629 | 0 | 427,629 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660684 |
| BVF GP HOLDINGS LLC | 9.6% | 13,140,690 | 0 | 13,140,690 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803809 |
| BVF PARTNERS L P/IL | 10% | 13,630,601 | 0 | 13,630,601 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001055947 |
| BVF INC/IL | 10% | 13,630,601 | 0 | 13,630,601 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001056807 |
| LAMPERT MARK N | 10% | 13,630,601 | 0 | 13,630,601 | /s/ Mark N. Lampert | Mark N. Lampert | 0001233840 |
| R. Thorvald Nagel | 0% | 0 | 0 | 0 | /s/ R. Thorvald Nagel | R. Thorvald Nagel |